Cost effectiveness of decentralised care model for managing MDR-TB in India
Keywords: Cost-effectiveness analysis; MDR-TB; Decentralised care; Centralised care; India;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)
Keywords: Delamanid; Mycobacterium tuberculosis; MDR-TB; Nitroimidazole;
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB)
Keywords: Antibiotics; Multidrug-resistant tuberculosis; MDR-TB; Extensively drug-resistant tuberculosis; XDR-TB;
Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data
Keywords: Diabetes mellitus; Delay; Sputum and culture conversion; MDR-TB; High treatment adherence;
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings
Keywords: MDR-TB; XDR-TB; Shorter regimen; Treatment duration; Efficacy; Impact;
Factors affecting tuberculosis case detection in Kersa District, South West Ethiopia
Keywords: Tuberculosis; Diagnosis; Case detection; Factors; TB; Tuberculosis; WHO; World Health Organization; MDR-TB; Multidrug Resistant Tuberculosis; AFB; Acid Fast Bacilli; HIV; Human Immune Deficient Virus; DOTS; Directly Observed Treatment Short Course; HCW; H
RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea
Keywords: Aminoglycosides; Efflux pump; Fluoroquinolones; MDR-TB; Tuberculosis; XDR-TB;
Molecular modelling and docking analysis of katG and rpoB gene in MDR-TB isolates from North Central Indian population
Keywords: Sahariya tribe; MDR-TB; Molecular modelling; Docking;
Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: An operational research from Chennai, India
Keywords: DR-TB; drug resistant tuberculosis; MDR-TB; multidrug resistant tuberculosis; DST; drug susceptibility testing; DTP; diagnosis and treatment pathway; RNTCP; revised national tuberculosis programme; PMDT; programmatic management of drug resistant tuberculo
Secondary metabolites from Tetracera potatoria stem bark with anti-mycobacterial activity
Keywords: CFU/mL; Colony Forming units/millilitre; DMSO; Dimethyl Sulfoxide; MIC; Minimum Inhibitory Concentration; INT; p-Iodonitrotetrazolium Chloride; ATTC; American Type Culture Collection; WHO; World Health Organization; MDR-TB; multi-drug resistant Tuberculos
Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis
Keywords: Thioridazine; Tuberculosis; MDR-TB; Efflux pump; Indole;
The novel gene mtb192 is a candidate marker for the detection of multidrug-resistant Mycobacterium tuberculosis strains
Keywords: EMB; ethambutol; INH; isoniazid; MDR-TB; multidrug-resistant tuberculosis; RT-PCR; reverse transcription-polymerase chain reaction; RFP; rifampicin; SM; streptomycin; TB; tuberculosis; Mycobacterium tuberculosis; mtb192; Polymerase chain reaction; Multidr
Molecular characterization of Isoniazid and Rifampicin target genes in multi-drug resistant Mycobacterium tuberculosis isolates from southwest of Iran
Keywords: MTB; Mycobacterium tuberculosis; WHO; World Health Organization; MDR-TB; multi-drug resistant tuberculosis; INH; Isoniazid; RMP; Rifampicin; KatG; catalase-peroxidase enzyme; DST; Drug susceptibility Testing; RMPr; Rifampicin-resistant; Mycobacterium tube
Extensively drug-resistant tuberculosis (XDR-TB) in Morocco
Keywords: Mycobacterium tuberculosis; MDR-TB; XDR-TB; GenoType MTBDRsl; Morocco;
Laboratory evaluation of the Anyplex⢠II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance
Keywords: Mycobacterium tuberculosis; MDR-Tb; XDR-Tb; Multiplex-PCR; Real-time PCR;
Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies
Keywords: 4-Aminosalicylic acid (PubChem CID: 4649); Pyrazinamide (PubChem CID: 1046); Nicotinamide (PubChem CID: 936); Isonicotinamide (PubChem CID: 15074); Isoniazid (PubChem CID: 3767); Caffeine (PubChem CID: 2519); Theophylline (PubChem CID: 2153); Methanol (Pu
Management of multidrug resistant tuberculosis (MDR-TB) – Monitoring is the key to successful outcome
Keywords: MDR-TB; Monitoring; Adverse reaction; Outcome
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates
Keywords: MDR-TB; second-line drugs; sequence analysis; tuberculosis (TB); XDR-TB
False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load
Keywords: Tuberculosis; Molecular diagnostics; MDR-TB; Xpert MTB/RIF; Developing and high-burden countries;
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
Keywords: Mtb; Mycobacterium tuberculosis; TB; Tuberculosis; MDR-TB; Multidrug-resistant tuberculosis; RIF; Rifampicin; INH; Isoniazid; PZA; Pyrazinamide; ETH; Ethambutol; WHO; World Health Organization; CYP; Cytochrome P450; ADME; Absorption, distribution, metabol
An urgent need for building technical capacity for rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB) among new cases: A case report from Maharashtra, India
Keywords: MDR-TB; New cases; Technical capacity; Rapid diagnosis; India
Multidrug-resistant TB among previously treated TB cases: A retrospective study in Nagpur, India
Keywords: Previously treated; MDR-TB; RNTCP; Relapse; Failures;
Hypothyroidism in MDR-TB treatment – Rare occurrence but a major concern
Keywords: Hypothyroidism; MDR-TB; Adverse drug reaction
Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium
Keywords: MDR-TB; XDR-TB; clinical management; drug resistance; prevention; ERS/WHO Consilium
Multidrug-resistant Mycobacterium tuberculosis and associated risk factors in Oromia Region of Ethiopia
Keywords: Risk factors; MDR-TB; Ethiopia; Africa
Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis
Keywords: MDR-TB; Mycobacterium tuberculosis; Pyridine; Thiadiazole; Clinical isolates
Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns
Keywords: Mycobacterium tuberculosis; MDR-TB; DOTS; Non-DOTS; Tuberculosis (TB);
Anti-TB drug resistance in Tanga, Tanzania: A cross sectional facility-base prevalence among pulmonary TB patients
Keywords: Pulmonary tuberculosis; Prevalence; Drug resistance; MDR-TB; HIV; Facility-base
Cost effectiveness of treating multi-drug resistant tuberculosis by adding Deltyba⢠to background regimens in Germany
Keywords: Cost effectiveness-analysis; Monte Carlo simulation; Tuberculosis; MDR-TB;
The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania
Keywords: Mycobacterium tuberculosis; Nucleic acid amplification test; Drug susceptibility testing; Xpert MTB/RIF assay; DST; drug susceptibility tests; HIV; human immunodeficiency virus; LJ; Lovenstein-Jensen medium; MDR-TB; multidrug-resistant tuberculosis; MGIT;
Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
Keywords: AFB; acid-fast bacilli; Mab; Mycobacterium abscessus; MAC; Mycobacterium avium complex; MDR-TB; multidrug-resistant TB; MTB; Mycobacterium tuberculosis; NTM; nontuberculous mycobacterial; QTc; corrected QT; TIW; three times weekly; UTHSCT; University of T
Car windshield fragments as cheap alternative glass beads for homogenization of Mycobacterium tuberculosis cultures in a resource-limited setting
Keywords: Glass beads; Drug susceptibility test; Tuberculosis culture; MDR-TB
Xpert MTB/RIF: The newly endorsed TB diagnostic
Keywords: Tuberculosis; GeneXpert; MDR-TB; EPTB; RT-PCR
Changes in nitric oxide synthase and nitrite and nitrate serum levels in patients with or without MDR-TB undergoing the intensive phase of anti-tuberculosis therapy
Keywords: MDR-TB, multi-drug resistant TB; MTB, Mycobacterium tuberculosis; NO, nitric oxide; iNOS, inducible NO synthase; NDTB, newly diagnosed TB; RTB, recurrent TBPulmonary tuberculosis; MDR-TB; MTB; Nitric oxide; NO; Inducible NO synthase
Deciphering the sequential events during in vivo acquisition of drug resistance in Mycobacterium tuberculosis
Keywords: Mycobacterium tuberculosis; MDR-TB; CAS1_Delhi genotype; Spoligotyping; Sequential isolates
Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
Keywords: Bedaquiline; Multidrug-resistant tuberculosis; MDR-TB; Diarylquinoline;
Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis
Keywords: Pyrazinamide; High resolution melt; Genotypic; MDR-TB;
Antibacterial activities of plants from Central Africa used traditionally by the Bakola pygmies for treating respiratory and tuberculosis-related symptoms
Keywords: CFU/mL; colony forming units/mL; DMSO; dimethyl sulfoxide; DCM; dichloromethane; MeOH; methanol; MIC; minimum inhibitory concentration; INT; iodonitrotetrazolium chloride; ATCC; American type culture collection; WHO; World Health Organization; MDR-TB; mul
Programmed death-1 receptor suppresses γ-IFN producing NKT cells in human tuberculosis
Keywords: Programmed death-1; Natural killer T cell; T helper-1; Effector T cells; Inteferon-gamma; APCs; antigen presenting cells; ATD; anti-tubercular drugs; Ag; antigen; Cat-I; category-I; Cat-II; category-II; HCs; healthy controls; IFN-γ; interferon gamma; IL-
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development
Keywords: Tuberculosis; anti-TB drugs; MDR-TB; XDR-TBAADAC, arylacetamide deacetylase; AUC, area under the curve; BTZ, benzothiazinone; CFM, clofazimine; CFU, colony forming units; Cfx, ciprofloxacin; DPA, decaprenylphosphoryl-β-D-arabinose; DprE1, decaprenylphosph
Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation
Keywords: Antimycobacterial; Isoniazid; MDR-TB; TDR-TB; LL-3858; In vivo;
Drug-resistant tuberculosis in the WHO European Region: An analysis of surveillance data
Keywords: Tuberculosis; Surveillance; Drug-resistance; MDR-TB; European Region;
Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis
Keywords: Bedaquiline; MDR-TB; XDR-TB; ATP synthase inhibitor; Tuberculosis;
Multidrug-resistant Myobacterium tuberculosis caused by the Beijing genotype and a specific T1 genotype clone (SIT No. 266) is widely transmitted in Minsk
Keywords: MDR-TB; Spoligotyping; pncA Gene; Molecular epidemiology
Multidrug resistant tuberculosis versus non-tuberculous mycobacterial infections: a CT-scan challenge
Keywords: MDR-TB; NTM; Tuberculosis
Microarray detection of fungal infection in pulmonary tuberculosis
Keywords: Mycotic infection; Pulmonary tuberculosis; MDR-TB; DNA microarray
Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine
Keywords: Methadone maintenance; Tuberculosis; HIV/AIDS; MDR-TB; Treatment retention; Adherence; Substance Abuse; Opioid dependence; Ukraine
Inactivation of multidrug resistant (MDR)- and extensively drug resistant (XDR)-Mycobacterium tuberculosis by photodynamic therapy
Keywords: MDR-TB; XDR-TB; D-value; PDT
Detection of extensively drug resistant pulmonary tuberculosis
Keywords: MDR-TB; EDR-TB; DOTS
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives
Keywords: Green synthesis; Ultrasonic irradiation; MDR-TB; Anti-infective activity; Pyrazolines;